In the Journals

Top pulmonology news from December: Nontuberculous mycobacterial lung disease, mild OSA treatment and more

January 10, 2020
Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in December. See below for…

Healio's top pulmonology news from 2019: Updates in asthma, COPD, vaping-related lung injury and more

December 31, 2019
As 2019 comes to a close, the Healio Pulmonology Editors have compiled a list of the most-read articles published this year. Our readers were…

Top cystic fibrosis updates from 2019: Triple therapy approved, invasive mechanical ventilation reduces mortality and more

December 30, 2019
The Healio Pulmonology Editors have compiled a list of updates in cystic fibrosis that Healio reported on in 2019. See below for news on a new triple…


Q&A: Success of triple therapy in cystic fibrosis

December 19, 2019
Two studies — one published in The New England Journal of Medicine and one published in The Lancet — have shown the promise of…

Meeting News

Top pulmonology news from October: ERS International Congress coverage, effects of e-cigarettes and more

November 8, 2019
Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in October. See below for links…

In the Journals

Outcomes better with triple therapy in cystic fibrosis with F508del mutation

November 1, 2019
When compared with treatment with tezacaftor plus ivacaftor alone, triple combination therapy with elexacaftor/tezacaftor/ivacaftor improved lung…

In the Journals

Triple therapy safe, effective in cystic fibrosis with single Phe508del allele

October 31, 2019
Combination therapy with elexacaftor/tezacaftor/ivacaftor improved lung function and the rate of pulmonary exacerbations with minimal adverse effects…

FDA News

Triple therapy approved to treat cystic fibrosis

October 21, 2019
The FDA announced it has approved elexacaftor/ivacaftor/tezacaftor, the first triple combination therapy for patients with the most common cystic…

In the Journals

Lower airway infection prevalence changing in children with cystic fibrosis

September 27, 2019
The prevalence of lower airway infections with Pseudomonas aeruginosa, Staphylococcus aureus and Haemophilus influenzae among young children with…

In the Journals

Mortality rates decreasing in cystic fibrosis patients treated with invasive mechanical ventilation

August 29, 2019
Mortality rates in adults with cystic fibrosis treated with invasive mechanical ventilation have decreased over time, suggesting mechanical…

In the Journals

Clofazimine safe, well-tolerated alternative for M. abscessus infection

August 2, 2019
Clofazimine was a safe and well-tolerated part of a multidrug regimen used to treat children with odontogenic Mycobacterium abscessus infection that…

Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations

August 2, 2019
Healio Pulmonology has you covered. The Editors have compiled a list of the most-popular articles posted on Healio Pulmonology in July. See below for…

FDA News

First triple combination therapy for cystic fibrosis submitted to FDA for review

July 25, 2019
A new drug application for a triple combination regimen of elexacaftor plus tezacaftor/ivacaftor has been submitted to the FDA, with a request for…

In the Journals

Ivacaftor may reduce respiratory infections in cystic fibrosis

July 23, 2019
Among patients with cystic fibrosis, the use of ivacaftor was associated with a 32% reduction in the rate of Pseudomonas aeruginosa infection and a…

In the Journals

Palivizumab does not improve long-term outcomes in kids with cystic fibrosis

July 19, 2019
Palivizumab — a monoclonal antibody that prevents respiratory syncytial virus, or RSV, in high-risk infants — did not improve long-term…

In the Journals

Azithromycin treatment outcomes may differ based on antibiotic type

July 16, 2019
Patients with cystic fibrosis saw a greater increase in FEV1 when given oral azithromycin in combination with certain IV antibiotics for the…

In the Journals

Hypertonic saline may be appropriate intervention for preschoolers with cystic fibrosis

June 26, 2019
New data from the SHIP study show that inhaled hypertonic saline, as compared with isotonic saline, improved lung clearance index in children aged 3…

FDA News

FDA expands Symdeko indication for cystic fibrosis in children as young as 6

June 21, 2019
The FDA has expanded the indication for combination tezcaftor/ivacaftor tablets to include treatment of cystic fibrosis in children aged 6 years and…

In the Journals

Cystic fibrosis-specific variables improve predicted disease severity in patients on waitlist

June 19, 2019
New data suggest that the addition of clinical variables specifically associated with reduced survival in cystic fibrosis to the lung allocation…

In the Journals

PRESIS: Hypertonic saline safe, effective in infants with cystic fibrosis

June 10, 2019
A clinical trial including lung clearance index and MRI as measures for early lung disease was feasible and showed that preventive inhalation…

Healio Jobs